HK1121468A1 - Synthetic mecp2 sequence for protein substitution therapy - Google Patents
Synthetic mecp2 sequence for protein substitution therapyInfo
- Publication number
- HK1121468A1 HK1121468A1 HK09101479.9A HK09101479A HK1121468A1 HK 1121468 A1 HK1121468 A1 HK 1121468A1 HK 09101479 A HK09101479 A HK 09101479A HK 1121468 A1 HK1121468 A1 HK 1121468A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- protein
- proteins
- nucleic acid
- relates
- substitution therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2006/003203 WO2007115578A1 (en) | 2006-04-07 | 2006-04-07 | Synthetic mecp2 sequence for protein substitution therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1121468A1 true HK1121468A1 (en) | 2009-04-24 |
Family
ID=36589309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK09101479.9A HK1121468A1 (en) | 2006-04-07 | 2009-02-17 | Synthetic mecp2 sequence for protein substitution therapy |
Country Status (16)
Country | Link |
---|---|
US (1) | US8226930B2 (de) |
EP (1) | EP2010563B1 (de) |
JP (1) | JP5102283B2 (de) |
CN (1) | CN101415726B (de) |
AT (1) | ATE500265T1 (de) |
AU (1) | AU2006341726B2 (de) |
CA (1) | CA2647125C (de) |
DE (1) | DE602006020501D1 (de) |
DK (1) | DK2010563T3 (de) |
ES (1) | ES2362195T3 (de) |
HK (1) | HK1121468A1 (de) |
HR (1) | HRP20110386T1 (de) |
IL (1) | IL194274A (de) |
PL (1) | PL2010563T3 (de) |
SI (1) | SI2010563T1 (de) |
WO (1) | WO2007115578A1 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1398191B1 (it) * | 2010-02-17 | 2013-02-14 | Ist Superiore Sanita | Uso di tossine che attivano le rho gtpasi per il trattamento e/o la prevenzione della sintomatologia associata alla sindrome di rett (rtt). |
JP6336755B2 (ja) | 2010-11-12 | 2018-06-06 | ザ ジェネラル ホスピタル コーポレイション | ポリコームに関連する非コードrna |
US9920317B2 (en) | 2010-11-12 | 2018-03-20 | The General Hospital Corporation | Polycomb-associated non-coding RNAs |
WO2013173608A1 (en) | 2012-05-16 | 2013-11-21 | Rana Therapeutics, Inc. | Compositions and methods for modulating mecp2 expression |
US10174323B2 (en) | 2012-05-16 | 2019-01-08 | The General Hospital Corporation | Compositions and methods for modulating ATP2A2 expression |
JP2015523854A (ja) | 2012-05-16 | 2015-08-20 | ラナ セラピューティクス インコーポレイテッド | Smn遺伝子ファミリー発現を調節するための組成物及び方法 |
AU2013262656A1 (en) | 2012-05-16 | 2015-01-22 | Rana Therapeutics, Inc. | Compositions and methods for modulating UTRN expression |
AP2014008100A0 (en) | 2012-05-16 | 2014-12-31 | Gen Hospital Corp | Compositions and methods for modulating hemoglobingene family expression |
US10837014B2 (en) | 2012-05-16 | 2020-11-17 | Translate Bio Ma, Inc. | Compositions and methods for modulating SMN gene family expression |
WO2014130408A1 (en) * | 2013-02-20 | 2014-08-28 | The Research Foundation For The State University Of New York | Regulators of rab5 activity |
CA2966044A1 (en) | 2014-10-30 | 2016-05-06 | The General Hospital Corporation | Methods for modulating atrx-dependent gene repression |
WO2016149455A2 (en) | 2015-03-17 | 2016-09-22 | The General Hospital Corporation | The rna interactome of polycomb repressive complex 1 (prc1) |
TWI601821B (zh) * | 2016-04-15 | 2017-10-11 | 中央研究院 | 治療神經發展性疾病 |
US11969479B2 (en) * | 2017-03-24 | 2024-04-30 | The University Court Of The University Of Edinburgh | MeCP2 expression cassettes |
US11629342B2 (en) | 2017-10-17 | 2023-04-18 | President And Fellows Of Harvard College | Cas9-based transcription modulation systems |
KR102052097B1 (ko) * | 2017-11-30 | 2019-12-05 | 한국과학기술연구원 | Mecp2 단백질 또는 이를 암호화하는 폴리뉴클레오티드를 포함하는 퇴행성 뇌질환 예방 또는 치료용 조성물 |
JP2022530095A (ja) * | 2019-04-24 | 2022-06-27 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | レット症候群の治療に有用な組成物 |
WO2023235648A1 (en) * | 2022-06-03 | 2023-12-07 | The Regents Of The University Of California | Nuclear Delivery and Transcriptional Repression with a Cell-penetrant MeCP2 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1157275A4 (de) | 1999-02-28 | 2003-01-15 | Univ Washington | Neue transduktionsmoleküle und verfahren zum benutzen derselben |
US6709817B1 (en) | 1999-09-07 | 2004-03-23 | Baylor College Of Medicine | Method of screening Rett syndrome by detecting a mutation in MECP2 |
US20040126877A1 (en) * | 2001-04-20 | 2004-07-01 | Man-Wook Hur | Repressors for hiv transcription and methods thereof |
JP5830213B2 (ja) * | 2004-02-17 | 2015-12-09 | ザ ホスピタル フォー シック チルドレン | Mecp2e1遺伝子 |
-
2006
- 2006-04-07 DK DK06724141.4T patent/DK2010563T3/da active
- 2006-04-07 PL PL06724141T patent/PL2010563T3/pl unknown
- 2006-04-07 CN CN2006800541487A patent/CN101415726B/zh not_active Expired - Fee Related
- 2006-04-07 EP EP06724141A patent/EP2010563B1/de active Active
- 2006-04-07 WO PCT/EP2006/003203 patent/WO2007115578A1/en active Application Filing
- 2006-04-07 ES ES06724141T patent/ES2362195T3/es active Active
- 2006-04-07 DE DE602006020501T patent/DE602006020501D1/de active Active
- 2006-04-07 SI SI200631023T patent/SI2010563T1/sl unknown
- 2006-04-07 AT AT06724141T patent/ATE500265T1/de active
- 2006-04-07 CA CA2647125A patent/CA2647125C/en not_active Expired - Fee Related
- 2006-04-07 JP JP2009503417A patent/JP5102283B2/ja not_active Expired - Fee Related
- 2006-04-07 AU AU2006341726A patent/AU2006341726B2/en not_active Ceased
- 2006-04-07 US US12/295,856 patent/US8226930B2/en active Active
-
2008
- 2008-09-22 IL IL194274A patent/IL194274A/en not_active IP Right Cessation
-
2009
- 2009-02-17 HK HK09101479.9A patent/HK1121468A1/xx not_active IP Right Cessation
-
2011
- 2011-05-24 HR HR20110386T patent/HRP20110386T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
AU2006341726B2 (en) | 2012-09-20 |
DE602006020501D1 (de) | 2011-04-14 |
WO2007115578A8 (en) | 2008-10-30 |
EP2010563B1 (de) | 2011-03-02 |
CN101415726B (zh) | 2013-07-31 |
JP5102283B2 (ja) | 2012-12-19 |
IL194274A (en) | 2011-07-31 |
CA2647125A1 (en) | 2007-10-18 |
CA2647125C (en) | 2015-02-03 |
DK2010563T3 (da) | 2011-05-23 |
US8226930B2 (en) | 2012-07-24 |
HRP20110386T1 (hr) | 2011-08-31 |
SI2010563T1 (sl) | 2011-07-29 |
US20090233856A1 (en) | 2009-09-17 |
ATE500265T1 (de) | 2011-03-15 |
WO2007115578A1 (en) | 2007-10-18 |
JP2009532045A (ja) | 2009-09-10 |
ES2362195T3 (es) | 2011-06-29 |
EP2010563A1 (de) | 2009-01-07 |
AU2006341726A1 (en) | 2007-10-18 |
CN101415726A (zh) | 2009-04-22 |
PL2010563T3 (pl) | 2011-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1121468A1 (en) | Synthetic mecp2 sequence for protein substitution therapy | |
MX2009012650A (es) | Secuencias de aminoacido dirigidas contra rank-l y polipeptidos que comprenden lo mismo para el tratamiento de enfermedades y trastornos de huesos. | |
ZA202002094B (en) | Trispecific proteins and methods of use | |
WO2007104529A3 (en) | Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling | |
MX2010005783A (es) | Secuencias de aminoacidos dirigidas contra citoquinas heterodimericas y/o sus receptores y polipeptidos que comprenden las mismas. | |
MX2018010824A (es) | Proteinas de union inducibles y metodos de uso. | |
CA2818990A1 (en) | Designed repeat proteins binding to serum albumin | |
WO2008074839A3 (en) | Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders | |
IN2012DN02981A (de) | ||
BR112019005587A2 (pt) | proteínas de ligação recombinantes e sua utilização | |
WO2010115998A3 (en) | Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders | |
MX359953B (es) | Ácido nucleico que comprende o que codifica un tallo-rizo de histona y una secuencia poli (a) o una señal de poliadenilación para incrementar la expresión de una proteína terapéutica codificada. | |
BR112012029588A2 (pt) | materiais biológicas relacionados a her3. | |
BR112016002753A2 (pt) | anticorpos contra o inibidor-1 de ativador de plasminogênio (pai-1) e usos dos mesmos | |
BRPI1010880A2 (pt) | polipeptídeos de hormônio de crescimento e métodos de fazer e usar os mesmos. | |
MX2022013520A (es) | Polipeptidos que se enlazan a cxcr2. | |
MX2009004243A (es) | Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal. | |
WO2011036442A3 (en) | Thrombin c- terminal polypeptides and uses thereof for treating inflammation coagulation disorders | |
EP3747457A3 (de) | Faktor-1-protein, faktor-2-protein und inhibitoren davon zur verwendung bei der behandlung und prävention von erkrankungen | |
UA100127C2 (ru) | Пептид cdh3 и лекарственное средство, содержащее его | |
WO2010115995A3 (en) | Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders | |
WO2009047513A3 (en) | Antagonists of kisspeptin and uses thereof | |
WO2007145589A8 (en) | Peptides that are capable of binding to amyloid-beta peptide. | |
WO2010011994A3 (en) | Polypeptides and uses thereof | |
WO2009037183A3 (de) | Nukleinsäurehaltige kosmetische und/oder pharmazeutische zubereitung zur induktion antimikrobieller peptide in epithelialen deckgeweben |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20180407 |